Nitrate-enhanced gated technetium 99m sestamibi SPECT for evaluating regional wall motion at baseline and during low-dose dobutamine infusion in patients with chronic coronary artery disease and left ventricular dysfunction: Comparison with two-dimensional echocardiography

Journal of Nuclear Cardiology

Volumn 7, Issue 5, 2000, Pages 426-431

  Leoncini, Mario ^a,b   Marcucci, Gabriella ^a,b   Sciagrà, Roberto ^a,b   Frascarelli, Fabio ^a,b   Traini, Anna Maria ^a,b   Mondanelli, Dante ^a,b   Magni, Massimo ^a,b   Bini, Luciano ^a,b   Bellandi, Francesco ^a,b   Mennuti, Alberto ^a,b   Dabizzi, Roberto Piero ^a,b  

^a MISERICORDIA E DOLCE HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Echocardiography; Gated single photon emission computed tomography; Low dose dobutamine; Myocardial viability; Sestamibi

Indexed keywords

DOBUTAMINE; ISOSORBIDE DINITRATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; DRUG INFUSION; DRUG RESPONSE; DYSKINESIA; FEMALE; GATED IMAGING; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE WALL MOTION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT CORONARY ARTERY; MALE; PRIORITY JOURNAL; RELIABILITY; REST; RIGHT CORONARY ARTERY; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0033760525     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2000.108029     Document Type: Article

References (28)

1. Gated SPECT imaging
2. Comparison of Tc-99m sestamibi and T1-201 gated perfusion SPECT
3. Value of gating technetium-99m sestamibi single-photon emission computed tomography imaging
4. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT
5. Automation of gated tomographic left ventricular ejection fraction
6. Left ventricular function in patients with coronary artery disease assessed by gated tomographic myocardial perfusion images. Comparison with assessment by contrast ventriculography and fist-pass radionuclide angiography
7. Relationship of gated SPECT ventricular function parameters to angiographic measurements
8. Evaluation of left ventricular wall motion, volumes and ejection fraction by gated myocardial tomography with technetium 99m-labeled tetrofosmin: A comparison with cine magnetic resonance imaging
9. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thallium-201 scintigraphy
10. Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography
11. Regional myocardial motion and thickening assessed at rest by ECG-gated Tc-99m-MIBI emission tomography and by magnetic resonance imaging
12. Gated technetium-99m tetrofosmin SPECT and cine MRI to assess left ventricular contraction
13. Reliability of enhanced gated SPECT in assessing wall motion of severely hypoperfused myocardium: Echocardiographic validation
14. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: Feasability and reliability for prediction of postrevascularization outcome of asynergic territories
15. Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery
16. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease
17. Dobutamine stress echocardiography: Correlation with coronary lesion severity as determined by quantitative angiography
18. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction
19. Regional myocardial wall thickening and global ejection fraction in patients with low angiographic left ventricular ejection fraction assessed by visual and quantitative resting ECG-gated 99m-Tc tetrofosmin tomography and magnetic resonance imaging
20. Functional assessment with electrocardiographic gated single-photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predicts myocardial viability revascularization
21. 99mTc-tetrofosmin SPECT for prediction of functional recovery defined by MRI in patients with severe left ventricular dysfunction: Additional value of gated SPECT
22. Methodology of a novel myocardial viability protocol
23. Dobutamine Tc-99m sestamibi gated SPECT: New methods for myocardial viability in patients with left ventricular dysfunction and coronary artery disease
24. Wall motion assessment by gated SPECT perfusion imaging in patients with ischemic cardiomyopathy
25. ECG-GATED low dose dobutamine Tc-99m sestamibi SPECT myocardial perfusion imaging accurately predicts myocardial viability: Comparison with rest-redistribution thallium-201
26. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: Comparison of pooled data
27. Significance of rest technetium-99m sestamibi imaging for the prediction of improvement of left ventricular dysfunction after Q wave myocardial infarction: Importance of infarct location adjusted thresholds
28. Fluorine-18 deoxyglucose PET for the assessment of viable myocardium in perfusion defects in 99mTc-MIBI SPECT: A comparative study in patients with coronary artery disease